The publication costs for the articles published in Clinical Phytoscience are sponsored by the Michael A. Popp nature science foundation (formerly the Phytoneering Foundation), so authors do not need to pay the article processing charge following acceptance of their manuscript. The Editorial Board acts independently of the sponsoring support. Each submitted article undergoes peer review following the common established editorial and ethical standards in publishing.
Aims and scope
Clinical Phytoscience is an international, peer-reviewed, interdisciplinary, and open access journal publishing high quality research articles on clinical evidence and use of medicinal plants in the development of efficient and well tolerated phytotherapy.
Clinical Phytoscience focuses on phytotherapy, looking at proof of concept, efficacy and safety, to be established “at eye level” compared to pharmacotherapy. The emphasis lies on application oriented topics (efficacy and safety of phytotherapy in a specific indication, including its need and acceptance by the patient). The scientific results published in the journal should contribute to the recovery and maintenance of human health by phytotherapy.
Clinical Phytoscience will publish high-quality evidence-based clinical studies and relevant pharmacological studies. Key areas of interest are:
- Upper and lower airways, ENT and pneumology
- Intestinal tract
- Diabetes/metabolic Syndrome
- Immunology and microbiology
The journal publishes original contributions, review articles (upon invitation; applications may be sent to the Editor in Chief) and short communications (letters). Articles are published after a rigorous and independent peer-review by an international board of experts. The journal is directed at medical doctors in clinic and practice and pharmacologists.
Clinical Phytoscience does not accept purely descriptive pre-clinical work without translational aspects for publication.
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Annual Journal Metrics
83 days to first decision for reviewed manuscripts only
71 days to first decision for all manuscripts
158 days from submission to acceptance
38 days from acceptance to publication
4 Altmetric mentions
- ISSN: 2199-1197 (electronic)